Allison Tsai


Dermatologist wins $101M in Florida's first Powerball

November 03, 2009

Tallahassee, Fla.- William Steele, M.D., an Orlando dermatologist, is Florida's first Powerball winner, taking a lump sum of $101 million, rather than $189 million spread over 20 years, according to the Bureau News.

Physician social networking Web site goes live

November 03, 2009

National report -, a physician-exclusive Web site designed to offer social and professional networking, has gone live.

Provectus expands compassionate use for PV-10

November 03, 2009

National report - Provectus Pharmaceuticals has expanded its compassionate use program for PV-10, which is being developed as a therapeutic agent for metastatic melanoma and other cancers, making it available for select cancer patients in the United States, according to a press release.

ASDS recognizes Dr. Neil Sadick for excellence in education

November 03, 2009

Phoenix - The American Society for Dermatologic Surgery (ASDS) presented Neil Sadick, M.D., with the Excellence in Education Award for his "significant commitment time and energy to teach dermatologic surgery and promote the advancement of the specialty," according to Robert Weiss, M.D., president of ASDS.

AAD launches kid-friendly interactive Web site

November 03, 2009

Schaumburg, Ill. - The American Academy of Dermatology (AAD) is launching an interactive Web site designed to teach kids ages 8-12, and their parents, healthy habits for their skin, hair and nails, according a press release.

Leo regains U.S. rights from Warner Chilcott for dermatology products

October 06, 2009

International report ? Leo Pharma, Denmark, is paying $1 billion in cash to reacquire U.S. rights held by Warner Chilcott for the company?s psoriasis portfolio and dermatology pipeline, Pharma Times reports.

Vitamin D may increase chance of melanoma survival

October 06, 2009

Leeds, England ? Higher levels of Vitamin D are associated with thinner lesions and a lower rate of relapse in melanoma patients, according to a study published in the Journal of Clinical Oncology.

Melanoma drug breaks new ground

October 06, 2009

New York ? Scientists are heralding Plexxikon?s experimental melanoma drug as a "breakthrough" after it successfully shrank patients? tumors in a clinical trial, according to

FDA approves Stelara for treatment of psoriasis

October 06, 2009

Horsham, Pa. ? The U.S. Food and Drug Administration (FDA) has approved the biologic Stelara (ustekinumab, Centocor Ortho Biotech) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, according to a Centocor press release.

Spain's 1st full face transplant patient smiles

September 01, 2009

International report - The patient who received Spain’s first full face transplant smiled about his new appearance, according to